Trending NewsTrending NewsNASDAQ:SRRK Scholar Rock (SRRK) Stock Price, News & Analysis $43.21 0.00 (0.00%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$43.39 +0.18 (+0.41%) As of 04:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Scholar Rock Stock (NASDAQ:SRRK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Scholar Rock alerts:Sign Up Key Stats Today's Range$42.76▼$44.1650-Day Range$39.60▼$57.4252-Week Range$34.25▼$61.76Volume623,508 shsAverage Volume1.59 million shsMarket Capitalization$5.27 billionP/E RatioN/ADividend YieldN/APrice Target$67.67Consensus RatingModerate Buy Company Overview Scholar Rock is a biopharmaceutical company based in Cambridge, Massachusetts, that develops medicines targeting growth factors and signaling proteins involved in disease. Its research has focused on the transforming growth factor beta (TGF-β) superfamily, which plays roles in processes including muscle development and immune regulation. The company’s lead program has been apitegromab, a selective inhibitor of myostatin developed for spinal muscular atrophy (SMA). Scholar Rock has studied the medicine as a potential treatment alongside existing SMA therapies, with the goal of improving patients’ motor function. Scholar Rock was founded in 2012. Its research and development programs have also included medicines targeting TGF-β signaling in cancer, reflecting the company’s broader approach of developing therapies that modulate the activation of growth factors.AI Generated. May Contain Errors. Read More Scholar Rock Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreSRRK MarketRank™: 3.326727440875 of 5 starsScholar Rock scored higher than 67% of companies evaluated by MarketBeat, and ranked 265th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingScholar Rock has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 3 strong buy ratings, 10 buy ratings, 2 hold ratings, and 2 sell ratings.Upside PotentialScholar Rock has a consensus price target of $67.67, representing about 56.6% upside from its current price of $43.21.Amount of Analyst CoverageScholar Rock has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Scholar Rock's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Scholar Rock are expected to grow in the coming year, from ($3.04) to ($2.80) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Scholar Rock is -12.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Scholar Rock is -12.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioScholar Rock has a P/B Ratio of 17.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted21.49% of the float of Scholar Rock has been sold short.Short Interest Ratio / Days to CoverScholar Rock has a short interest ratio ("days to cover") of 13.58, which indicates bearish sentiment.Change versus previous monthShort interest in Scholar Rock has recently increased by 5.87%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldScholar Rock does not currently pay a dividend.Dividend GrowthScholar Rock does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.39 News SentimentScholar Rock has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 33 news articles for Scholar Rock this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for SRRK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Scholar Rock to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Company Ownership3.9 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $12,000,582.00 in company stock, which represents 0.2276% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Scholar Rock insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,000,582.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.30% of the stock of Scholar Rock is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions91.08% of the stock of Scholar Rock is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Scholar Rock's insider trading history. Receive SRRK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Scholar Rock and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRRK Stock News HeadlinesScholar Rock (NASDAQ:SRRK) Stock Rating Lowered by Wolfe ResearchNovember 14 at 3:03 AM | americanbankingnews.comHC Wainwright Boosts Earnings Estimates for Scholar RockNovember 14 at 1:56 AM | americanbankingnews.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected. | Porter & Company (Ad)Biotech dealmaker: Early-stage platforms and tools draw capital as full buyouts remain on the sidelines this weekNovember 13 at 11:40 PM | msn.comHC Wainwright Predicts Scholar Rock Q1 EarningsNovember 13 at 1:59 AM | americanbankingnews.comAnalysts Offer Insights on NA Companies: SpaceX (SPCX) and Scholar Rock Holding (SRRK)November 11, 2026 | theglobeandmail.comScholar Rock (SRRK) Q3 2026 Earnings Call TranscriptNovember 10, 2026 | finance.yahoo.comScholar Rock (NASDAQ:SRRK) Director Srinivas Akkaraju Purchases 142,500 Shares of StockOctober 28, 2026 | insidertrades.comSee More Headlines SRRK Stock Analysis - Frequently Asked Questions How have SRRK shares performed this year? Scholar Rock's stock was trading at $44.05 at the beginning of 2026. Since then, SRRK shares have decreased by 1.9% and is now trading at $43.21. How were Scholar Rock's earnings last quarter? Scholar Rock Holding Corporation (NASDAQ:SRRK) posted its quarterly earnings data on Tuesday, November, 10th. The company reported ($0.81) EPS for the quarter, topping analysts' consensus estimates of ($0.85) by $0.04. The business earned $570 thousand during the quarter, compared to analyst estimates of $304 thousand. Read the conference call transcript. When did Scholar Rock IPO? Scholar Rock (SRRK) raised $75 million in an initial public offering (IPO) on Thursday, May 24th 2018. The company issued 5,360,000 shares at a price of $13.00-$15.00 per share. Jefferies, Cowen and BMO Capital Markets served as the underwriters for the IPO and Wedbush PacGrow was co-manager. Who are Scholar Rock's major shareholders? Scholar Rock's top institutional shareholders include State Street Corp (3.59%), Voya Investment Management LLC (0.77%), GW&K Investment Management LLC (0.30%) and Pictet Asset Management Holding SA (0.30%). Insiders that own company stock include Public Equities LP Invus, Srinivas Akkaraju, David Hallal, Akshay Vaishnaw, Keith Woods, Keith Woods, Vikas Sinha, Jay T Backstrom, Junlin Ho, Caryn Parlavecchio, Jing L Marantz, Kristina Burow, Edward H Myles, Mo Qatanani, Tracey Sacco, Michael Gilman, Katie Peng, Jeffrey S Flier and Joshua Reed. View institutional ownership trends. How do I buy shares of Scholar Rock? Shares of SRRK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Scholar Rock own? Based on aggregate information from My MarketBeat watchlists, some other companies that Scholar Rock investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Rocket Lab (RKLB), Micron Technology (MU), Eli Lilly and Company (LLY), Vertiv (VRT) and Nebius Group (NBIS). Company Calendar Last Earnings11/10/2026Today11/15/2026UBS Global Biopharma Conference 202611/16/2026Jefferies Global Healthcare Conference11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (12m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 SRRK's financial health is in the Green zone, according to TradeSmith. SRRK has been in this zone for over 12 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:SRRK CIK1727196 Webwww.scholarrock.com Phone(857) 259-3860Fax866-493-4935Employees289Year Founded2012Price Target and Rating Average Price Target for Scholar Rock$67.67 High Price Target$84.00 Low Price Target$42.00 Potential Upside/Downside+56.6%Consensus RatingModerate Buy Rating Score (0-4)2.82 Research Coverage17 Analysts Profitability EPS (Trailing Twelve Months)($3.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$377.94 million Net MarginsN/A Pretax Margin-72,563.16% Return on Equity-175.27% Return on Assets-86.66% Debt Debt-to-Equity Ratio1.16 Current Ratio5.41 Quick Ratio5.40 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.41 per share Price / Book17.93Miscellaneous Outstanding Shares122,000,000Free Float109,438,000Market Cap$5.27 billion OptionableOptionable Beta0.78 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NASDAQ:SRRK) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredGlobal Industrial Powerhouse Taps Nasdaq Drone MicrocapA Nasdaq-listed drone company just signed an exclusive agreement with Prime Strategic Holdings, part of billio...The Tomorrow Investor | SponsoredATTENTION: Elon’s silent partnerElon Musk's plan to take AI beyond Earth and put data centers into orbit is what Tim Bohen calls Mission X. Hi...Millionaire Pub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scholar Rock Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Scholar Rock With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.